Beat Inflation with These “Fabulous Five” Stocks And, enjoy healthy yields— to help you stay ahead Beat Inflation with These “Fabulous Five” Stocks And, enjoy healthy yields—to help you stay ahead Inflation—especially core inflation—largely has Moreover, Americans will increasingly face
been muted by technical improvements and the
(alongside all of humanity) the ravages of resource
increasing cost efficiencies of information tech-
scarcity, which will inevitably and inexorably raise
nologies (IT) that offset the impact of rising prices
costs of every basic necessity, from food and fuel
in other arenas. But eventually, years of quantitative
to transportation and health care. Wise investors
easing, both by U.S. and foreign governments, will
should therefore always hold in their portfolios
some core stocks to offset their ever-rising costs,
preferably of companies that over time have proven
their ability and commitment to steadily increase dividends, distributions or other payouts—while
But the apparent slog ahead should not impede
continuing to grow the businesses on which they and long-term returns to Novartis shareholders. Quite their shareholders rely for those pay raises. In this
the opposite. While the stock dipped in the summer,
environment, bonds remain decidedly unhelpful.
it again rose to new highs in September. The markets
Actually, one must turn back to the 1950s to find
cheered the company’s mid term guidance, and look
another modern era when it was so much easier to
forward to changes to be wrought under the new
get nice income from stocks than bonds. At present,
chairman—despite Vasella’s history of leading revo-
the relative value, yields and payouts of equities look lutionary growth. extraordinary when compared to fixed income. Be-low we suggest five hearty investments to help keep
Sales grew 3 percent in the second quarter of
your wealth and income rising, and to stave off the ill 2013, to $14.5 billion, despite patent expirations, and effects of inflation and rising prices.
core operating income rose 2 percent. Free cash flow for the second quarter alone remained high at nearly
Novartis (NVS) Great dividends are also available currently from That cash flow can certainly cover future divi-
the drug industry, and a favorite in that sector
dends, and says nothing about the continuing ad-
is Novartis (NVS), which has turned out one of the
vancement of Novartis innovation and productivity,
very few truly successful drugs in the past decade to
including 17 new drug approvals in 2012—such
successfully fight a moderately rare form of cancer.
as U.S. and EU approvals for Afinitor for advanced
Good growth should accompany its current yield of
breast cancer; an EU approval for Jakavi for myelofi-
brosis and a U.S. nod for Dailies Total1.
The company will continue growing despite the
As well as a good Committee for Medicinal
retirement of Daniel Vasella, a medical doctor who
Products for Human Use opinion for Bexsero, a
for a decade as its chief executive and chairman, built breakthrough meningococcal serogroup B vaccine,
Novartis into a huge growth engine after the 1996
received in the fourth quarter. Moreover, recent No-
merger of two flagging Swiss drug companies, Ci-
vartis innovations previously placed on the market
still have long runs ahead of them. MS, the debil-itating and often fatal neurological disease, affects
Vasella led Novartis into thriving trades in every-
some 2.5 million people worldwide and the growing
thing from the first oral drug for multiple sclerosis
market for Novartis’ genelia MS drug is expected to
and mass-market Diovan blood pressure pills, to
vaccines, Alcon eyecare products and generic medi-cations to highly focused breast cancer and leukemia
Novartis is a strong company with a terrific future,
drugs. Jorg Reinhardt, Vasella’s one-time right hand
and plenty of firepower to continue funding—and
man and a Ph.D. in pharmaceutical science, took
raising—its healthy dividend. This is a company to
the reigns as chairman in September, after two years
buy and to hold for the inflationary years ahead.
heading Bayer’s healthcare division. Diamond Offshore Drilling (DO)
Novartis now faces a kind of corporate drug
withdrawal in the form of the so-called patent cliff,
In the energy exploration sector, we recommend
as blood pressure hit Diovan loses its exclusive. The
Diamond Offshore (DO).
company predicts flat 2013 sales roughly in line with 2012, and a 2013 mid-to-single digit drop in profits
Diamond Offshore owns and operates one of
with returns to sales and profit growth expected only the world’s largest fleets of offshore drilling units;
including 30 semisubmersibles, 7 jack-ups and one
vestments. This, plus the recent debt upgrade, create
drillship, with two deepwater semisubmersibles un-
financial flexibility and further enhances our invest-
der construction scheduled for delivery in 2013 and
2014, respectively and an additional five rigs to come on line later on. Mandalay Resources (MND.T, MNDJF)
Its equipment lets the company offer equally
diverse worldwide services in both the floater (ul-
Our natural resource recommendation is Manda-
tra-deepwater, deepwater and mid-water) market
lay Resources (MND.T, MNDJF), an emerging
and the non-floater, or jack-up, markets. Often
junior miner with a relatively short history but the
criticized for its older fleet, Diamond Offshore in
makings of a real winner. It’s profitable and it even
fact for years had been investing in its fleet, devoting pays a dividend. nearly $4.2 billion in new capital to that purpose since 2009. Since then, the total number of rigs has
While chiefly a silver miner, the Toronto-based
declined, as the company retired several jackups and company is not a pure play; Mandalay generates midwater rigs, but focused on ultra-deepwater and
revenue (about $160 million in 2012) from several
deepwater markets. The company has 23 interna-
metals. About half of its revenue in 2013 will come
tional semsubmersibles, plus more several additional from silver sales, some 35 percent from gold and the “cold stacked” rigs.
Antimony is important as a fire retardant for
tra-deep-water market, where demand and day rates fabrics and plastics, and China is its major producer should remain strong for years.
and consumer, with control over more than half its global annual trade. As with rare earths, China has
Of course, at first glance, Diamond Offshore, as a
declared antimony a strategic mineral and in recent
deepwater driller, may not look too enticing to most
years restricted its export. Chinese economic growth
income investors: it’s not exactly in a recession-proof slowed somewhat this year but is again rising. In any business. Its yield, on the surface, does not look very
case, the market and demand for antimony should
high, either. However, over time the company has
remain strong for years. Some new antimony mines
consistently paid special quarterly dividends—and
are under development, but current global con-
said dividends, since mid 2010, have held steady at
sumption will exhaust known reserves within a de-
75 cents a share, including the most recent 75 cent
cade. Even if additional reserves are discovered, the
special dividend in late July. Add them, and the an-
price of antimony will rise—perhaps much higher.
Mandalay now has two operating mines (its Cerro
Since January 1, 2006, Diamond Offshore has
Bayo silver-gold mine in Chile and Costerfield, a
paid and declared over $37 per share in total overall
high-grade gold-antimony property in southeastern
dividends, and going forward, the special dividend
Australia). Purchased in 2009 from Coeur d’Alene
looks safe, as Loews Corporation owns over half of
Mines, Cerro Bayo has since tripled its resource
Diamond Offshore—and like all stockholders, reaps
base—now nearing 28 million silver-equivalent
the special dividend. Thus, with Loews as the major-
ounces—as well as its silver-equivalent output,
ity owner, we think there is little risk to the special
which hit some 3.4 million ounces in 2012 and could
top 4.6 million silver-equivalent ounces by 2014, at costs under $11 an ounce.
Another positive—compared to its indus-
try group—is Diamond Offshore’s balance sheet
Costerfield, bought in late 2009 from Western
strength: The size of its long-term debt is about
Coal, quickly expanded its resource base for antimo-
equal to total balance sheet cash and short-term in-
ny, a rare metal used for everything from electronics
to fire retardant in upholstery fabrics. China pro-
Aqua America management maintain this compa-
duces roughly 90 percent the world’s antimony. With ny in a relatively aggressive way, emphasizing acqui-Chinese export restrictions, Antimony prices dou-
sitions (nearly 200 acquisitions, plus joint growth
bled since 2010. It now sells for $13,000 per ton, and ventures in the last decade). The strategy pays off. we expect to see it rise much higher. By 2014, the
Yielding 2.5 percent, Aqua America provides inves-
company hopes to double the mine’s output, roughly tors with pure refreshment. 50-50 gold and antimony, to yield 80,000 to 100,000 gold-equivalent ounces. The project is self-financ-
Sempra Energy (SRE)
ing—and 90 percent of the district remains to be examined. There’s potential to add to the company’s Our fifth inflation-beating stock is Sempra Ener-
gy. We recommend Sempra Energy (SRE) for
reserves and diversify its revenue base.
those seeking to enhance their income and thwart inflation’s advance.
Mandalay’s La Quebrada copper-silver project in
Northern Chile contains an estimated 459 million
Created in 1998 from a merger of two long-es-
pounds of copper and 11.2 million ounces of silver.
tablished utilities, Sempra was founded to capitalize
Production remains several years off, but over time,
on utility deregulation and new energy business
we expect the market to recognize the property’s
competition. It offers above-average growth from
unregulated businesses, including liquefied natural gas terminals, pipelines, and storage facilities—but
The young company has grown without assuming also from its electric generation and energy-related
debt. Unique for a small cap miner, it pays a quar-
terly dividend, with a payout of 6 percent of trailing revenues. It recently yielded 3.6 percent. Manage-
With nearly 17,000 employees, Sempra Energy’s
ment owns about 15 percent of the stock and has
companies develop energy infrastructure, operate
strong incentives to grow. For now, Mandalay sells
utilities, and provide related products and services
at a big discount to its peers by a number of metrics. to over 31 million consumers worldwide. Its units
include California utilities (San Diego Gas & Electric
Aqua America (WTR)
Co. and Southern California Gas Co.) serving more than 20 million consumers as well as Sempra U.S.
Income-hungry investors can also benefit might- Gas & Power and Sempra International—develop-
ily from owning the water utility Aqua America
ing and operating critical energy infrastructure and
(WTR), which recently declared another increase—
provide gas and electricity services in North America
of 9 percent—in its quarterly cash dividend. The
increase came on an accelerated schedule, a quarter earlier than usual, and landed considerably higher
We like Sempra for its focus on shareholder value
than the 6 percent rate at which the dividend grew
and meeting customer needs through its own finan-
(on a compounded annual basis) for the last 22
cial strength, its operational flexibility and skilled
years. Aqua America remains a low-yielding utility,
workforce in fast-changing energy markets. But the
but we like it, as additional dividend increases are
company also invests in its future growth. In De-
cember 2012, for example, Sempra Energy applied to federal regulators for construction permits to add
Management noted that earnings gains in recent
natural gas liquefaction and export facilities to its
years lowered the payout ratio to around 50 percent existing Cameron LNG terminal in Hackberry, La. based on current earnings, and as a long-term goal, it seeks a payout ratio of 60 percent to 70 percent.
Similarly, a pipeline project in Mexico presages
Moreover, Aqua stock recently split, 5-for-4 (25
significant growth at Sempra International. Con-
struction on the project is planned to start in 2014,
with the expectation that the facility will begin deliv- last year, they should rise again soon. Sempra has, in ering LNG to international markets in 2017.
short, raised its 2013 guidance on earnings per share
This company, once something of a commodity
by 20 cents and continues to expect $5.50 to $6.00 in
trader, exited that business through divestiture. For
2013, it has issued updated guidance expectant of earnings between $4.30 and $4.60 a share, including
Moreover, the company may form an MLP for
rate increases for both its California utilities, before
its midstream and LNG assets, further adding to its
Its 2013 revenues should easily exceed $10.5 bil-
Despite its recent strong run, Sempra still looks
lion and its earnings are smartly advancing, meaning like it can add value. The potential from its lique-that the 63 cent quarterly dividend (increased in
faction business—the company’s $6 billion LNG
February) and recently yielding nearly 2.9 percent,
export terminal at Cameron, Louisiana now on track
should continue to grow. That seems to be the con-
to add new capabilities—will allow for gains from
clusion of the stock market, moreover, where Sem-
LNG export growth in Asia, where natural gas prices
pra’s shares recently topped $85, having more than
tie more closely to oil prices. And the share price
does not yet reflect either of those developments, nor possible MLP creation. LNG is a big deal. The
This has been a champion performer for income
Cameron terminal will have a projected capacity of
investors, and continues to promise a great future.
13.5 million tonnes annually, and once operational
And where dividends grew nearly 14 percent in the
It is a violation of the United States copyright laws for any person or entity to reproduce, copy or use this document, in part or whole, without the express permission
of the publisher. All rights are reserved. @2013 LIM As used in this Disclaimer, the words “we”, “us” and “our” refer to any or all of TCI Enterprises LLC (DBA The Complete Investor), Stephen Leeb’s Aggressive Trader LLC
(DBA Leeb’s Aggressive Trader), Natural Resources Advisory (DBA Leeb’s Real World Investing), Emerging Advisory LLC (DBA Leeb Income Performance), Leeb & Co.
LLC (DBA Leeb’s Million Dollar Portfolio), Fund World LLC (DBA The Cash Cow) Leeb Income Millionare (DBA Leeb Income Millionare) and all of their officers, directors,
managing directors, partners, agents and employees. We are not a broker-dealer or investment adviser, and are not registered as such with state or federal regulators. Past results cited by us are as of the date of pub-
lication and not as of any subsequent date, and opinions expressed and information and data provided herein are subject to change without notice. We do not make
any representations or warranties regarding the information and/or content we publish, do not guarantee any particular results, and disclaim any responsibility for the
outcome of any investments that you choose to make. Readers should consider their personal situation before making any investment decisions. While reviewing
financial information and general recommendations can be an important tool for educated investors, it is not a substitute for obtaining advice from a qualified invest-
ment professional familiar with your personal circumstances. We recommend that you seek the advice of such a professional in evaluating any specific security, report,
opinion, or other content. We highly recommend that investors consult licensed tax professionals for personally-tailored advice appropriate to individual situations. Our officers, directors, employees, associated entities and/or clients of associated entities may currently maintain direct or indirect ownership positions in securities
discussed in the information and date herein, or in securities such as options or warrants the underlying exposure of which are securities discussed herein. Our general
policy is to prohibit our officers, directors, and/or employees from purchasing positions or increasing existing positions in companies referenced in our information
and/or content for a period of two (2) days following dissemination, and from disposing of any positions in companies referenced in our information and/or content
SEVERE ALLERGIC REACTION/504 PLAN & MEDICATION ORDERS Birthdate: Allergy History: Skin testing indicates allergy Date of Last Reaction : Other Allergies: Student has Asthma (increased risk factor for severe reaction) Anaphylaxis (Severe allergic reaction) is an excessive reaction by the body to combat a foreign substance that has been eaten, injected, inhaled or
Honig- Ginseng Granulat Das moderne koreanische Energiepaket für Vitalität aus der Natur liegt jetzt u.a. unter dem Handels-namen HoneySweet Ginseng vor. Honig und Ginseng gehören zu den ältesten Energie- und Vitalitätsspendern der Menschheits-geschichte. Aus Bernsteinfunden ist bekannt, dass es schon seit 40- 50 Millionen Jahren Bienen auf unserer Erde gibt. Die Menschen haben schon